16Sep 2019

ADHERENCE TO ANTIRETROVIRAL THERAPY MEDIATE THE RELATIONSHIP BETWEEN BOTH LIFE AND PSYCHOLOGICAL STRESSES WITH VIRAL LOAD AMONG HIV-POSITIVE PATIENTS.

  • Department of Industrial Engineering King Abdulaziz University, Jeddah, Saudi Arabia.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Adherence to treatment plays an important role in controlling the HIV disease. However, treatment adherence might be affected by different factors such as stressful life event and psychological distress. Therefore, the goals of this study were to investigate the effects of both of types of stresses on adherence and viral load, and to investigate the association between both stresses ? that were being mediated by adherence ? with the viral load. In this study, 140 HIV-positive patients participated in the 3-month period study. Stressful life events were measured using Life Events Survey (LES). Psychological stresses were quantified using Kessler Psychological Distress Scale (K10). Both types of stress significantly affected adherence and viral load. Moreover, both stresses and treatment adherence significantly affected viral load. Additional, the association between both types of stresses and viral load was significantly mediated by treatment adherence. Therefore, clear understanding of these mechanisms will aid HIV program managers, growth partners, and researchers in developing strategies to increase adherence awareness.


  1. Remmert JE, et al. Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav. 2015;19:981?6. 8.
  2. Brown JL, Littlewood RA, Vanable PA. Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city. AIDS Care 2013;25(9):1149?58. 9.
  3. Malow R, D?vieux JG, Stein JA, Rosenberg R, Jean-Gilles M, Attonito J, et al. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav 2013;17(4):1221?30.
  4. Adolescent HIV Testing, Counselling and Care: Implementation Guidance for Health Providers and Planners. Available at: http://apps.who.int/adolescent/hiv-testing-treatment/page/Psychosocial_well_being (last accessed on October 20, 2018) 5.
  5. Remien RR, Rabkin JG. Psychological aspects of living with HIV disease: A primary care perspective. West J Med 2001;175(5):332?5.
  6. Vranda MN, Mothi SN. Psychosocial issues of children infected with HIV/AIDS. Indian J Psychol Med 2013;35(1):19?22.
  7. Katz S, Nevid JS. Risk factors associated with posttraumatic stress disorder symptomatology in HIV-infected women. AIDS Patient Care STDs 2005;19:110?120.
  8. Carmona A, Knobel H, Guelar A, et al. Factors influencing survival in HIV infected patients treated with HAART. Presented at 13th International AIDS Conference. Durban, South Africa, July 9?14, 2000.
  9. Walsh JC, Hertogs K, Gazzard B. Viral drug adherence and pharmacokinetic indices in HIV-1 infected patients on successful and failing protease inhibitor (PI) based highly active antiretroviral therapy (HAART). Presented at the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy. Toronto, Canada, September 17?20, 2000.
  10. Hewitt R, Roberts JE, Shelton MJ, Esch LD. Psychological factors and future adherence to antiretroviral therapy. Poster presented at the 1st International AIDS Society Conference on HIV Pathogenesis and Treatment. Buenos Aires, Argentina, July 8?11, 2000.
  11. Nevid JS. Risk factors associated with posttraumatic stress disorder symptomatology in HIV-infected women. AIDS Patient Care STDs 2005;19:110?120.
  12. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: Development of the Life Experiences Survey. J Consult ClinPsychol 1978;46:932?946.
  13. Sarason IG, Johnson JH. The Life Experiences Survey: Preliminary findings. Technical Report SCS-LS-001. Office of Naval Research, 1976
  14. Leserman J, Whetten K, Lowe K, Stangl D, Swartz MS, Thielman NM. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med 2005;67:500?507.
  15. Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosom Med 1999;61:397?406.
  16. Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition, and mortality: Psychosocial and physiological predictors. Psychol Med 2002;32:1059?1073.
  17. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-Inf
  18. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003 Feb;60(2):184-9.
  19. O?Cleirigh C, Ironson G, Smits JA. Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? BehavTher 2007;38:314?323.
  20. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune DeficSyndr 2006;43(Suppl 1):S23?S35.
  21. Lwanga SK, Lemeshow S. Sample Size Determination in Health Studies, a Practical Manual. Geneva: World Health Organization, 1991. pp. 1?3. Available at: http://apps.who.int/ iris/ handle/10665/40062 (last accessed on November 11, 2018).
  22. Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV?infected youth. Top HIV Med 2009;17(1):14?25.
  23. Agwu AL, Fairlie L. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc 2013;16:18579.
  24. Mavhu W, Berwick J, Chirawu P, Makamba M, Copas A, Dirawo J, et al. Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe. PLoS ONE 2013;8(7):e70254.
  25. Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat 2012;2012:574656. Available at: http://dx.doi. org/10.1155/2012/574656 (last accessed on September 26, 2018).
  26. Kathryn A. Bottonari, John E. Roberts, Jeffrey A. Ciesla, And Ross G. Hewitt, Life Stress and Adherence to Antiretroviral Therapy among HIV-Positive Individuals: A Preliminary Investigation. AIDS PATIENT CARE and STDs. Volume 19: 717- 727.
  27. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries, Pediatr Infect Dis J 2008;27(8):686?91.
  28. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296(6):679?90.
  29. Simoni JM, Montgomery A, Martin EM, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007;119(6):1371?83.

[Rami H. Alamoudi. (2019); ADHERENCE TO ANTIRETROVIRAL THERAPY MEDIATE THE RELATIONSHIP BETWEEN BOTH LIFE AND PSYCHOLOGICAL STRESSES WITH VIRAL LOAD AMONG HIV-POSITIVE PATIENTS. Int. J. of Adv. Res. 7 (Sep). 772-778] (ISSN 2320-5407). www.journalijar.com


Dr. Rami H Alamoudi
Associate Professor

DOI:


Article DOI: 10.21474/IJAR01/9727      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9727